Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,849 | 522 | 98.8% |
| Education | $110.50 | 9 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,936 | 186 | $0 (2024) |
| Janssen Biotech, Inc. | $668.41 | 35 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $639.31 | 40 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $442.46 | 31 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $365.36 | 19 | $0 (2023) |
| Merck Sharp & Dohme LLC | $359.24 | 24 | $0 (2023) |
| Boston Scientific Corporation | $337.13 | 5 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $287.69 | 20 | $0 (2018) |
| Allergan, Inc. | $284.19 | 23 | $0 (2020) |
| PFIZER INC. | $258.11 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $984.44 | 61 | ABBVIE INC. ($579.08) |
| 2023 | $1,353 | 72 | AbbVie Inc. ($369.83) |
| 2022 | $1,235 | 73 | ABBVIE INC. ($452.89) |
| 2021 | $1,025 | 62 | AbbVie Inc. ($354.79) |
| 2020 | $774.17 | 43 | AbbVie Inc. ($334.78) |
| 2019 | $1,083 | 63 | AbbVie, Inc. ($224.18) |
| 2018 | $1,244 | 80 | AbbVie, Inc. ($383.49) |
| 2017 | $1,261 | 77 | AbbVie, Inc. ($236.73) |
All Payment Transactions
531 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: INFLIXIMAB | ||||||
| 10/21/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: INFLIXIMAB | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: GI | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Immunology | ||||||
| 08/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 897 | 953 | $822,135 | $108,260 |
| 2022 | 18 | 1,031 | 1,133 | $839,309 | $117,030 |
| 2021 | 17 | 972 | 1,046 | $860,001 | $116,443 |
| 2020 | 16 | 940 | 1,003 | $862,724 | $123,612 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 141 | 142 | $181,902 | $27,852 | 15.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 70 | 70 | $66,640 | $12,070 | 18.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 69 | 69 | $65,550 | $11,960 | 18.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 164 | 166 | $175,130 | $11,708 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 91 | $28,574 | $8,049 | 28.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 61 | 61 | $58,011 | $7,842 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 114 | $24,624 | $6,784 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $21,988 | $5,007 | 22.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $48,600 | $4,740 | 9.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $11,196 | $2,681 | 23.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 21 | $63,525 | $2,139 | 3.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 34 | 34 | $27,098 | $2,031 | 7.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 27 | $5,805 | $1,626 | 28.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 12 | $7,200 | $1,585 | 22.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2023 | 12 | 13 | $31,793 | $1,096 | 3.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,499 | $1,090 | 24.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 131 | 131 | $167,811 | $25,264 | 15.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 159 | 163 | $171,965 | $12,505 | 7.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 70 | $42,000 | $10,472 | 24.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 57 | 57 | $54,150 | $9,898 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 140 | $30,240 | $8,730 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 97 | $30,458 | $8,542 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $30,114 | $7,142 | 23.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 54 | 54 | $51,354 | $7,138 | 13.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 106 | $22,790 | $5,735 | 25.2% |
About Dr. Carley Ebanks, M.D
Dr. Carley Ebanks, M.D is a Gastroenterology healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558301341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carley Ebanks, M.D has received a total of $8,960 in payments from pharmaceutical and medical device companies, with $984.44 received in 2024. These payments were reported across 531 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,849).
As a Medicare-enrolled provider, Ebanks has provided services to 3,840 Medicare beneficiaries, totaling 4,135 services with total Medicare billing of $465,345. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Macon, GA
- Active Since 06/08/2006
- Last Updated 05/23/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1558301341
Products in Payments
- XIFAXAN (Drug) $597.85
- HUMIRA (Biological) $475.04
- STELARA (Biological) $435.39
- Mavyret (Drug) $412.54
- RINVOQ (Biological) $396.46
- LINZESS (Drug) $393.50
- CREON (Drug) $392.52
- OCALIVA (Drug) $365.36
- CLENPIQ (Drug) $350.80
- VIBERZI (Drug) $322.24
- Trulance (Drug) $287.69
- Humira (Biological) $270.44
- XELJANZ (Drug) $258.11
- SKYRIZI (Biological) $236.26
- IBSRELA (Drug) $223.29
- REMICADE (Biological) $211.76
- DIFICID (Drug) $192.71
- Linzess (Drug) $184.16
- INTERSTIM (Device) $180.61
- ZEPATIER (Drug) $166.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Macon
Dr. Daniel Penn, M.d, M.D
Gastroenterology — Payments: $196,237
Dr. Adam Levy, M.d, M.D
Gastroenterology — Payments: $74,787
Dr. Raymond Bedgood, D.o, D.O
Gastroenterology — Payments: $21,324
Joel Judah, Md, MD
Gastroenterology — Payments: $13,591
Dr. William Fackler, Md, MD
Gastroenterology — Payments: $7,328
Shahriar Sedghi, M.d, M.D
Gastroenterology — Payments: $7,263